Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis

Published:2023-11 Issue: Volume:194 Page:113358
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Martins-Branco Diogo^ORCID,Nader-Marta Guilherme,Molinelli Chiara,Ameye Lieveke,Paesmans Marianne,Ignatiadis Michail,Aftimos Philippe,Salgado Roberto,de Azambuja Evandro

Funder

Université Libre de Bruxelles

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference41 articles.

1. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials;Asselain;Lancet Oncol,2018

2. Adjuvant capecitabine for breast cancer after preoperative chemotherapy;Masuda;N Engl J Med,2017

3. Trastuzumab emtansine for residual invasive HER2-positive breast cancer;von Minckwitz;N Engl J Med,2019

4. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer;Tutt ANJ;N Engl J Med,2021

5. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis;Cortazar;Lancet,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysis;European Journal of Cancer;2024-09

2. Letter re: Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: A systematic review and meta-analysis;European Journal of Cancer;2024-08

3. Ki67 Tumor Expression Predicts Treatment Benefit Achieved by Macroscopic Radical Lung-Preserving Surgery in Pleural Mesothelioma—A Retrospective Multicenter Analysis;Cancers;2024-05-10

4. Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota;Frontiers in Oncology;2024-03-27